Lee Danner & Bass Inc. Trims Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Lee Danner & Bass Inc. lessened its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 22.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,687 shares of the real estate investment trust’s stock after selling 14,691 shares during the quarter. Lee Danner & Bass Inc.’s holdings in Healthpeak Properties were worth $1,027,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. State Street Corp purchased a new stake in Healthpeak Properties in the 3rd quarter valued at $1,093,576,000. Geode Capital Management LLC purchased a new stake in Healthpeak Properties in the 3rd quarter valued at $403,898,000. Principal Financial Group Inc. raised its position in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after purchasing an additional 17,314,572 shares during the last quarter. Charles Schwab Investment Management Inc. purchased a new stake in Healthpeak Properties in the 3rd quarter valued at $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Healthpeak Properties in the 3rd quarter valued at $175,697,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on DOC. Robert W. Baird cut their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Scotiabank cut their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research report on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Mizuho cut their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Finally, StockNews.com upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $20.02 on Friday. The stock has a market cap of $14.00 billion, a PE ratio of 57.19, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a fifty-two week low of $17.45 and a fifty-two week high of $23.26. The firm’s fifty day simple moving average is $20.24 and its 200-day simple moving average is $21.17. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 6.10%. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.